Takeuchi, Tsutomu https://orcid.org/0000-0003-1111-8218
Tanaka, Yoshiya
Soen, Satoshi
Yamanaka, Hisashi
Yoneda, Toshiyuki
Tanaka, Sakae
Nitta, Takaya
Okubo, Naoki
Genant, Harry K
van der Heijde, Désirée https://orcid.org/0000-0002-5781-158X
Funding for this research was provided by:
Daiichi Sankyo Co., Ltd
This article is maintained by: Elsevier
Article Title: Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial
Journal Title: Annals of the Rheumatic Diseases
CrossRef DOI link to publisher maintained version: https://doi.org/10.1136/annrheumdis-2018-214827
Content Type: article
Copyright: Copyright © 2019 © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.